Meet our Team
-
Allison is a pharmaceutical researcher and consultant with expertise in the implementation of managed access pathways, innovative market access agreements, real-world data enablement, and patient support programs in Canada.
She routinely speaks and writes about the Canadian pharmaceutical sector, notably on the intersection of activities between Canada’s health technology assessors (Canada’s Drug Agency, INESSS), government (public payers, the pCPA), private insurers, patient organizations, pharmaceutical manufacturers, and patient support programs, and their impact on timely patient access to novel therapies.
Allison is the publisher of the quarterly magazine, The 20Sense Report, and co-chair of the Real-World Evidence & Outcomes-Based Agreements Working Group and the Patient Support Program Leaders Forum. She has co-authored six peer-reviewed publications on real-world evidence for healthcare decision-making and the implementation of innovative market access pathways and agreements in Canada.
-
Arif is an Industrial Engineer and strategic pharmaceutical consultant with expertise in process, data, and analytics. He leads real-world data and evidence research at 20Sense, with a focus on developing solutions for the implementation of managed access pathways and agreements, patient support program standards and best practices, and optimizing processes to support timely and appropriate patient access to innovative pharmaceuticals for Canadians.
Arif is the co-chair of the Real-World Evidence & Outcomes-Based Agreements Working Group and the Patient Support Program Leaders Forum. He has co-authored four peer-reviewed publications on real-world evidence for healthcare decision making, and the implementation of innovative market access pathways and agreements in Canada.